Factory Mutual Insurance Co. dramatically upped its stake in Regeneron Pharmaceuticals by 210.3%, acquiring an additional ...

J.P. Morgan sees mid-cap defense firms like Kratos rebounding in the second half of 2025 amid Pentagon-driven tailwinds.

Wells Fargo analyst Mohit Bansal maintained a Hold rating on Pfizer (PFE – Research Report) yesterday and set a price target of $28.00. The company’s shares closed yesterday a ...

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) is one of the 13 Biotech Stocks with Huge Upside Potential. JPMorgan has ...

Regeneron Pharmaceuticals just got a haircut from Wall Street, with JPMorgan Chase & Co. lowering its price target from $950 ...

Morgan Stanley has lowered its price target on Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) to $755 from $958, while maintaining an Overweight rating on the stock. The revision follows what the ...

On Monday, Bernstein SocGen Group lowered the price target for Regeneron Pharma stock (NASDAQ: NASDAQ:REGN) to $750 from $896, while maintaining an Outperform rating. This adjustment follows Regeneron ...

On Monday, Bernstein SocGen Group lowered the price target for Regeneron Pharma stock (NASDAQ: NASDAQ:REGN) to $750 from $896, while maintaining an Outperform rating. This adjustment follows ...

"It's oscillating between a high end, which prices in a very positive scenario where tariffs ... of Trump's tariffs is yet to be felt in both economic growth and inflation, JPMorgan strategist Mislav ...

Fintel reports that on May 30, 2025, Wells Fargo downgraded their outlook for Regeneron Pharmaceuticals (NasdaqGS:REGN) from Overweight to Equal-Weight. Analyst Price Forecast Suggests 68.40% Upside ...